首页> 外文学位 >Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation

【24h】

Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Feng, Xue.;
展开▼
作者单位

West Virginia University.;

展开▼
授予单位 West Virginia University.;
学科
学位 Ph.D.
年度 2018
页码 115 p.
总页数 115
原文格式 PDF
正文语种 eng
中图分类 AAI10792124;
关键词
Atrial fibrillation; Drug-drug interaction; Major bleeding; NOAC; Oral anticoagulant; Switching;

机译：心房颤动;药物 - 药物相互作用;重大出血;noac;口服抗凝血剂;交换;
入库时间 2022-08-17 12:01:21

相似文献

外文文献
中文文献
专利

1. Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants [J] . Feng Xue, Sambamoorthi Usha, Innes Kim, Cardiovascular drugs and therapy . 2018,第6期

机译：心房颤动的工作年龄成年人重大出血的预测因素：评估潜在药物 - 药物相互作用和从华法林切换到非维生素K口腔抗凝血剂的影响
2. Healthcare Utilization and Expenditures in Working-Age Adults with Atrial Fibrillation: The Effect of Switching from Warfarin to Non-Vitamin K Oral Anticoagulants [J] . Xue Feng, Usha Sambamoorthi, Kim Innes, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2018,第6期

机译：具有心房颤动的工作年龄成年人的医疗利用和支出：从华法林切换到非维生素K口腔抗凝剂的效果
3. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group [J] . Pharithi Rebabonye B., Ranganathan Deepti, OBrien Jim, Irish journal of medical science . 2019,第1期

机译：处方是否正确？非瓣膜心房颤动患者的非维生素K拮抗剂抗凝血剂（NOAC）处方述评。心房颤动和卒中中非维生素K口腔抗凝血剂的心房颤动和评价安全规定（安全Noacs）组
4. What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation? [C] . R. CAZZIN, P. SERRA, C. FUSILLI International Workshop on Cardiac Arrhythmias . 2004

机译：在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么？
5. The Bleeding Risk of Non-Vitamin K Antagonist Oral Anticoagulants in Cirrhotic Patients: A Systematic Review and Meta-Analysis [D] . Go, Rafael Francisco C. 2020

机译：肝硬化患者中非维生素K拮抗剂口腔抗凝剂的出血风险：系统审查和荟萃分析
6. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial [O] . Linda P T Joosten, Sander van Doorn, Arno W Hoes, 2019

机译：心衰纤弱的老年人从维生素K拮抗剂转换为非维生素K拮抗剂口服抗凝剂的安全性：FRAIL-AF随机对照试验的原理和设计
7. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis. [O] . Giuseppe Santarpia, Salvatore De Rosa, Alberto Polimeni, 2015

机译：非维生素K拮抗剂口服抗凝剂与维生素K拮抗剂口服抗凝剂在射频导管消融心房颤动患者中的疗效和安全性：meta分析。

Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation

著录项

相似文献

相关主题

期刊订阅